Maria Celeste Lechner

1.8k total citations
46 papers, 770 citations indexed

About

Maria Celeste Lechner is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Maria Celeste Lechner has authored 46 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Pharmacology and 13 papers in Oncology. Recurrent topics in Maria Celeste Lechner's work include Pharmacogenetics and Drug Metabolism (21 papers), Metabolism and Genetic Disorders (11 papers) and Drug Transport and Resistance Mechanisms (11 papers). Maria Celeste Lechner is often cited by papers focused on Pharmacogenetics and Drug Metabolism (21 papers), Metabolism and Genetic Disorders (11 papers) and Drug Transport and Resistance Mechanisms (11 papers). Maria Celeste Lechner collaborates with scholars based in Portugal, United States and France. Maria Celeste Lechner's co-authors include Vera Ribeiro, Teresa Pereira, Paula Leandro, Isabel Tavares de Almeida, Isabel Rivera, David Konecki, Mohammed Dehbi, Mohammad Hossein Ghahremani, Jerry Pelletier and Elsa Rodrigues and has published in prestigious journals such as Nucleic Acids Research, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Maria Celeste Lechner

44 papers receiving 751 citations

Peers

Countries citing papers authored by Maria Celeste Lechner

Since Specialization

Citations

This map shows the geographic impact of Maria Celeste Lechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Celeste Lechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Celeste Lechner more than expected).

Fields of papers citing papers by Maria Celeste Lechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Celeste Lechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Celeste Lechner. The network helps show where Maria Celeste Lechner may publish in the future.

Co-authorship network of co-authors of Maria Celeste Lechner

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Celeste Lechner. A scholar is included among the top collaborators of Maria Celeste Lechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Celeste Lechner. Maria Celeste Lechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GSTpi Expression in MPTP-Induced Dopaminergic Neurodegeneration of C57BL/6 Mouse Midbrain and Striatum 2008 ·Journal of Molecular Neuroscience ·Margarida Castro‐Caldas, Andreia Neves Carvalho, Isabel Peixeiro, Elsa Rodrigues, Maria Celeste Lechner, Maria João Gama	28
2	Transcriptional regulation of the human CYP46A1 brain‐specific expression by Sp transcription factors 2008 ·Journal of Neurochemistry ·Inês Milagre, Maria João Nunes, Maria João Gama, (unknown), Jean‐Marc Pascussi, Maria Celeste Lechner, Elsa Rodrigues	35
3	Association of A313 G polymorphism (GSTP1B) in the glutathione‐S‐transferase P1* gene with sporadic Parkinson's disease 2006 ·European Journal of Neurology ·R. Vilar, (unknown), Elsa Rodrigues, Maria João Gama, Isabel Rivera, Emanuela Taioli, Maria Celeste Lechner	29
4	Two CCAAT/enhancer binding protein sites in the cytochrome P4503A1 locus 2003 ·European Journal of Biochemistry ·Elsa Rodrigues, Marie‐José Vilarem, Vera Ribeiro, Patrick Maurel, Maria Celeste Lechner	12
5	Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study 2003 ·Biomarkers ·Kim M. Smits, Laura Gaspari, Matty P. Weijenberg, Vita Dolžan, Klaus Golka, H. Roemer, Vessela N. Kristensen, Maria Celeste Lechner, (unknown), Janeric Seidegård, Richard C. Strange, Emanuela Taioli	26
6	The Correlation of Genotype and Phenotype in Portuguese Hyperphenylalaninemic Patients 2000 ·Molecular Genetics and Metabolism ·Isabel Rivera, (unknown), Manuela Almeida, Paula Leandro, (unknown), (unknown), (unknown), Laura Vilarinho, Esmeralda Martins, Maria Celeste Lechner, Isabel Tavares de Almeida, David Konecki, Uta Lichter‐Konecki	14
7	Cerebral hemorrhage and apoE 1999 ·Journal of Neurology ·Carlos García, Teresa Pinho e Melo, Luísa Rocha, Maria Celeste Lechner	10
8	P450-Catalyzed In-Chain Desaturation of Valproic Acid: Isoform Selectivity and Mechanism of Formation of Δ3-Valproic Acid Generated by Baculovirus- Expressed CYP3A1 1998 ·Archives of Biochemistry and Biophysics ·Michael B. Fisher, (unknown), Vera Ribeiro, Maria Celeste Lechner, Allan E. Rettie	25
9	Allele frequency of CYP2C19 in a Portuguese population 1997 ·Pharmacogenetics ·Jorge L. Ruas, Maria Celeste Lechner	27
10	Developmental changes in the constitutive and inducible expression of cytochrome p450 3a2 1997 ·Biochemical Pharmacology ·Matthew C. Wright, Robert J. Edwards, (unknown), Vera Ribeiro, Gurpreet S. Ratra, Maria Celeste Lechner, Alan J. Paine	30
11	Relative frequency of IVS10nt546 mutation in a Portuguese phenylketonuric population 1997 ·Human Mutation ·Isabel Rivera, Paula Leandro, Uta Lichter‐Konecki, Isabel Tavares de Almeida, Maria Celeste Lechner	1
12	Mutation Analysis of phenylketonuria in South and Central Portugal: Prevalence of V388M mutation 1995 ·Human Mutation ·Paula Leandro, Isabel Rivera, Vera Ribeiro, Isabel Tavares de Almeida, (unknown), Maria Celeste Lechner	9
13	Differential Regulation of the Cytochrome P450 3A1 Gene Transcription by Dexamethasone in Immature and Adult Rat Liver 1995 ·European Journal of Biochemistry ·Teresa Pereira, Maria Celeste Lechner	12
14	Aging effects on hepatic NADPH cytochrome P450 reductase, CYP2B1 & 2, and polymeric immunoglobulin receptor mRNAs in male fischer 344 rats 1994 ·Experimental Gerontology ·Rutger L. van Bezooijen, Rose K. Wang, Maria Celeste Lechner, Douglas L. Schmucker	9
15	Cloning and characterization of a novel CYP3A1 allelic variant: Analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone 1992 ·Archives of Biochemistry and Biophysics ·Vera Ribeiro, Maria Celeste Lechner	58
16	Effect of dexamethasone and phenobarbital on run-on transcription rate and CYP3A mRNA concentration in rat liver: Changes during development 1992 ·Archives of Biochemistry and Biophysics ·(unknown), Teresa Pereira, Maria Celeste Lechner	44
17	Effect of Rat Developmental Stage at Initiation on the Expression of Biochemical Markers during Liver Tumor Promotion 1990 ·Tumor Biology ·(unknown), C. Lafarge‐Frayssinet, Margarida Barroso, Maria Celeste Lechner, (unknown), C Frayssinet	1
18	Modulation of P-450 IIC7 and IIIA1,2 mRNA in pre-neoplastic liver. Effect of promotion by phenobarbital 1990 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Maria Celeste Lechner, Margarida Barroso, (unknown), C. Lafarge‐Frayssinet, (unknown), C Frayssinet	1
19	The steroid antagonist RU38486 is metabolized by the liver microsomal P450 mono-oxygenases 1990 ·Biochemical and Biophysical Research Communications ·Sylvette Chasserot‐Golaz, Vera Ribeiro, (unknown), Maria Celeste Lechner, G. Beck	10
20	Expression of a constitutive form of cytochrome P450 during rat‐liver development and sexual maturation 1988 ·European Journal of Biochemistry ·Margarida Barroso, (unknown), Maria Celeste Lechner	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact